Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 475281 - 475300 out of 485022 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FE01) cetuximab | ERBITUX 100MG/50ML INJ SDV | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | EliLilly&Company |
| USA | (L01FE01) cetuximab | ERBITUX 200MG/100ML SDV | 1VIAL | Ex-factory price without vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | EliLilly&Company |
| USA | (L01FE01) cetuximab | ERBITUX 200MG/100ML SDV | 1VIAL | Ex-factory price without vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | EliLilly&Company |
| USA | (L01FE02) panitumumab | VECTIBIX 100MG/5ML INJ,SOLN SDV | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenUSA,Inc. |
| USA | (L01FE02) panitumumab | VECTIBIX 100MG/5ML INJ,SOLN SDV | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenUSA,Inc. |
| USA | (L01FE02) panitumumab | VECTIBIX 400G/20ML INJ,SOLN SDV | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenUSA,Inc. |
| USA | (L01FE02) panitumumab | VECTIBIX 400G/20ML INJ,SOLN SDV | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenUSA,Inc. |
| USA | (L01FE03) necitumumab | PORTRAZZA 800MG/50ML | 50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | EliLilly&Company |
| USA | (L01FE03) necitumumab | PORTRAZZA 800MG/50ML | 50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | EliLilly&Company |
| USA | (L01FF01) nivolumab | OPDIVO 100MG/10ML INJ | 1X10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FF01) nivolumab | OPDIVO 10MG/ML INJ,SOLN 24ML | 24ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FF01) nivolumab | OPDIVO 120MG VIAL | 12ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FF01) nivolumab | OPDIVO 40MG/4ML INJ | 1X4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FF02) pembrolizumab | KEYTRUDA 100MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeLLC |
| USA | (L01FF02) pembrolizumab | KEYTRUDA 100MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeLLC |
| USA | (L01FF02) pembrolizumab | KEYTRUDA 100MG INJ | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeLLC |
| USA | (L01FF02) pembrolizumab | KEYTRUDA 100MG INJ | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeLLC |
| USA | (L01FF03) durvalumab | IMFINZI 120MG INJ | 120MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF03) durvalumab | IMFINZI 120MG INJ | 120MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF03) durvalumab | IMFINZI 500MG INJ | 500MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
Pages
